Carlo Lazzaro

1.0k total citations
47 papers, 742 citations indexed

About

Carlo Lazzaro is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carlo Lazzaro has authored 47 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carlo Lazzaro's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Neutropenia and Cancer Infections (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Carlo Lazzaro is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Neutropenia and Cancer Infections (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Carlo Lazzaro collaborates with scholars based in Italy, United States and France. Carlo Lazzaro's co-authors include Robert West, Laura Carrozzi, Carlos A. Jiménez-Ruíz, Giovanni Viegi, Christina Gratziou, K.O. Fagerström, S Nardini, Philip Tønnesen, Leonardo Lopiano and Dario Cocito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Respiratory Journal.

In The Last Decade

Carlo Lazzaro

41 papers receiving 704 citations

Peers

Countries citing papers authored by Carlo Lazzaro

Since Specialization

Citations

This map shows the geographic impact of Carlo Lazzaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Lazzaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Lazzaro more than expected).

Fields of papers citing papers by Carlo Lazzaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Lazzaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Lazzaro. The network helps show where Carlo Lazzaro may publish in the future.

Co-authorship network of co-authors of Carlo Lazzaro

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Lazzaro. A scholar is included among the top collaborators of Carlo Lazzaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Lazzaro. Carlo Lazzaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology Units	Pathologica	Carlo Lazzaro, Giovanni Fattore et al.	2
2	Cost&ndash;Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany	Dove Medical Press (Taylor and Francis Group)	Carlo Lazzaro, Ulrich Thelen et al.	3
3	Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy	Neurological Sciences	Carlo Lazzaro, Roberto Bergamaschi et al.	2
4	Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis	Bone Marrow Transplantation	Carlo Lazzaro, Luca Castagna et al.	4
5	Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up	Respiratory Medicine	Angelo Guido Corsico, Fulvio Braido et al.	4
6	AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: An cost-utility analysis	Journal of Rehabilitation Medicine	Carlo Lazzaro, Alessio Baricich et al.	13
7	Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis	SHILAP Revista de lepidopterología	Carlo Lazzaro, Fabio Parazzini et al.	0
8	A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample	ClinicoEconomics and Outcomes Research	Michela Meregaglia, Carlo Lazzaro et al.	21
9	Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole Study	Value in Health	Carlo Lazzaro, Maria Cappello et al.	0
10	Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and France: A Markov Model-Based Cost-Effectiveness Analysis	Value in Health	Carlo Lazzaro, Roberto F.E. Pedretti et al.	0
11	An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study	ClinicoEconomics and Outcomes Research	Carlo Lazzaro, Roberto Bordonaro et al.	23
12	FASTCAP study on the management of hospitalized patients with community-acquired pneumonia: pharmacoeconomic analysis of the prospective phase	SHILAP Revista de lepidopterología	Carlo Lazzaro, Ido Iori et al.	1
13	Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon β-1b	Neurological Sciences	Carlo Lazzaro, Cosetta Bianchi et al.	28
14	Consensus conference on the management of tumor lysis syndrome	Haematologica	Patrizia Tosi, Giovanni Barosi et al.	89
15	Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy	European Respiratory Journal	Philip Tønnesen, Laura Carrozzi et al.	171
16	Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.	PubMed	Carlo Lazzaro et al.	24
17	Efficacy and Safety of Short Course (5-day) Moxifloxacinvs7-day Ceftriaxone in the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB)	Journal of Chemotherapy	C Grassi, L Gobio Casali et al.	36
18	The Effects of a Mechanical Thrombolytic Device on Normal Canine Vein Valves	Journal of Vascular and Interventional Radiology	Gordon McLennan, Scott O. Trerotola et al.	18
19	Modified Use of the Arrow-Trerotola Percutaneous Thrombolytic Device for the Treatment of Thrombosed Hemodialysis Access Grafts	Journal of Vascular and Interventional Radiology	Carlo Lazzaro, Scott O. Trerotola et al.	35
20	Hereditary Desmoid Disease in a Family with a Germline <i>Alu I</i> Repeat Mutation of the APC Gene	Human Heredity	Kevin C. Halling, Carlo Lazzaro et al.	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact